Hana Višňová

699 total citations
11 papers, 260 citations indexed

About

Hana Višňová is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Urology. According to data from OpenAlex, Hana Višňová has authored 11 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Reproductive Medicine, 7 papers in Public Health, Environmental and Occupational Health and 2 papers in Urology. Recurrent topics in Hana Višňová's work include Ovarian function and disorders (7 papers), Reproductive Biology and Fertility (6 papers) and Sperm and Testicular Function (3 papers). Hana Višňová is often cited by papers focused on Ovarian function and disorders (7 papers), Reproductive Biology and Fertility (6 papers) and Sperm and Testicular Function (3 papers). Hana Višňová collaborates with scholars based in Czechia, Denmark and Spain. Hana Višňová's co-authors include Bjarke M. Klein, Manuel Fernández Sánchez, Joan‐Carles Arce, Anders Nyboe Andersen, Ernesto Bosch, Pedro N. Barri, Juan A. García-Velasco, Petra De Sutter, Pavel Ventruba and Bart C.J.M. Fauser and has published in prestigious journals such as Human Reproduction, Fertility and Sterility and Clinical Endocrinology.

In The Last Decade

Hana Višňová

9 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hana Višňová Czechia	7	223	201	103	22	13	11	260
Ashraf Alyasin Iran	9	161 0.7×	144 0.7×	61 0.6×	56 2.5×	23 1.8×	17	237
S. L. Tan Canada	5	265 1.2×	227 1.1×	103 1.0×	11 0.5×	10 0.8×	6	281
Ewa Pastuszek Poland	10	246 1.1×	186 0.9×	99 1.0×	19 0.9×	36 2.8×	19	324
L.E.T. Albuquerque Brazil	5	212 1.0×	164 0.8×	97 0.9×	15 0.7×	20 1.5×	8	245
Fariba Ramezanali Iran	10	220 1.0×	164 0.8×	72 0.7×	91 4.1×	20 1.5×	27	288
M. De Santo Italy	11	376 1.7×	315 1.6×	79 0.8×	12 0.5×	62 4.8×	15	439
Edward H. Illions United States	8	218 1.0×	182 0.9×	87 0.8×	15 0.7×	13 1.0×	16	305
Carolina Ortega‐Hrepich Belgium	10	320 1.4×	338 1.7×	114 1.1×	16 0.7×	53 4.1×	15	370
BJ Cohlen Netherlands	5	179 0.8×	114 0.6×	109 1.1×	8 0.4×	12 0.9×	6	201
Cailin Jordan Australia	4	132 0.6×	98 0.5×	31 0.3×	10 0.5×	9 0.7×	5	148

Countries citing papers authored by Hana Višňová

Since Specialization

Citations

This map shows the geographic impact of Hana Višňová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hana Višňová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hana Višňová more than expected).

Fields of papers citing papers by Hana Višňová

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hana Višňová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hana Višňová. The network helps show where Hana Višňová may publish in the future.

Co-authorship network of co-authors of Hana Višňová

This figure shows the co-authorship network connecting the top 25 collaborators of Hana Višňová. A scholar is included among the top collaborators of Hana Višňová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hana Višňová. Hana Višňová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Bellver, José, Juan A. García-Velasco, Hana Višňová, et al.. (2024). O-027 Efficacy results from the phase II randomized clinical trial: OXO-001 in infertile women undergoing egg donation IVF/ICSI. Human Reproduction. 39(Supplement_1).

Višňová, Hana, et al.. (2021). Clinical outcomes of potential high responders after individualized FSH dosing based on anti-Müllerian hormone and body weight. Reproductive BioMedicine Online. 43(6). 1019–1026. 8 indexed citations

Griesinger, Georg, Christophe Blockeel, Piotr Pierzyński, et al.. (2020). Effect of the oxytocin receptor antagonist nolasiban on pregnancy rates in women undergoing embryo transfer following IVF: analysis of three randomised clinical trials. Human Reproduction. 36(4). 1007–1020. 7 indexed citations

Sánchez, Manuel Fernández, Hana Višňová, Albert Yuzpe, et al.. (2018). Individualization of the starting dose of follitropin delta reduces the overall OHSS risk and/or the need for additional preventive interventions: cumulative data over three stimulation cycles. Reproductive BioMedicine Online. 38(4). 528–537. 27 indexed citations

Bosch, Ernesto, Anders Nyboe Andersen, Pedro N. Barri, et al.. (2015). Follicular and endocrine dose responses according to anti‐Müllerian hormone levels in IVF patients treated with a novel human recombinant FSH (FE 999049). Clinical Endocrinology. 83(6). 902–912. 15 indexed citations

Arce, Joan‐Carles, Anders Nyboe Andersen, Manuel Fernández Sánchez, et al.. (2014). Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone–stratified, dose–response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertility and Sterility. 102(6). 1633–1640.e5. 127 indexed citations

Višňová, Hana, et al.. (2003). [Importance of sensitization of insulin receptors in the prevention of ovarian hyperstimulation syndrome].. PubMed. 68(3). 155–62. 12 indexed citations

Hrubá, Drahoslava, et al.. (2003). Ascorbic acid and infertility treatment.. PubMed. 11(2). 63–7. 58 indexed citations

Višňová, Hana, et al.. (2003). [Recurrent interstitial pregnancy in uterine horn after IVF/ET].. PubMed. 68(3). 201–3. 1 indexed citations

10.

Crha, Igor, et al.. (2002). [Cryopreservation of sperm before neoplasm therapy--7 years' experience].. PubMed. 67(6). 324–8. 1 indexed citations

11.

Ventruba, Pavel, et al.. (1999). [Present possibilities of prevention of adhesions and their immunologic aspects].. PubMed. 64(4). 230–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact